This study describes the identification of an antibiotic class acting via LpxH, involved in lipopolysaccharide synthesis having potent in vivo efficacy against bloodstream infections caused by the critical Gram-negative pathogens E. coli and Klebsiella pneumoniae. Further development of this class of antibiotics could make an important contribution to the ongoing struggle against antibiotic resistance.
https://www.pnas.org/doi/10.1073/pnas.2317274121 (open access)
Good, now use it SPARINGLY unlike zpack
Yes, this is SPARTA! Pour it on everything quickly or we might all die!!1!
Agreed! Haha just kidding, prescription machine goes brrrrr